Litcius/Paper detail

Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial

Robert W. Mutter, Sharmila Giri, Briant Fruth, Nicholas B. Remmes, Judy C. Boughey, Christin A. Harless, Kathryn J. Ruddy, L.A. McGee, Arslan Afzal, Robert W. Gao, Dean A. Shumway, T.Z. Vern-Gross, Hector R. Villarraga, Stephanie L Kenison, Yixiu Kang, William W. Wong, Bradley J. Stish, Kenneth W. Merrell, Elizabeth Yan, Sean S. Park, Kimberly S. Corbin, Carlos Vargas

2023The Lancet Oncology29 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProton therapyRadiation therapyRandomized controlled trialPhase (matter)Medical physicsNuclear medicinePhysical therapyInternal medicinePhysicsQuantum mechanicsBreast Cancer Treatment StudiesRadiation Therapy and DosimetryBreast Implant and Reconstruction
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial | Litcius